Complete Remission in the Nephrotic Syndrome Study Network

被引：45

作者：

Gipson, Debbie S. ^{[1
]}

Troost, Jonathan P. ^{[1
]}

Lafayette, Richard A. ^{[1
]}

Hladunewich, Michelle A. ^{[1
]}

Trachtman, Howard ^{[1
]}

Gadegbeku, Crystal A. ^{[1
]}

Sedor, John R. ^{[1
]}

Holzman, Lawrence B. ^{[1
]}

Moxey-Mims, Marva M. ^{[1
]}

Perumal, Kalyani ^{[1
]}

Kaskel, Frederick J. ^{[1
]}

Nelson, Peter J. ^{[1
]}

Tuttle, Katherine R. ^{[1
]}

Bagnasco, Serena M. ^{[1
]}

Hogan, Marie C. ^{[1
]}

Dell, Katherine M. ^{[1
]}

Appel, Gerald B. ^{[1
]}

Lieske, John C. ^{[1
]}

Ilori, Titilayo O. ^{[1
]}

Sethna, Christine B. ^{[1
]}

Fervenza, Fernando C. ^{[1
]}

Hogan, Susan L. ^{[1
]}

Nachman, Patrick H. ^{[1
]}

Rosenberg, Avi Z. ^{[1
]}

Greenbaum, Larry A. ^{[1
]}

Meyers, Kevin E. C. ^{[1
]}

Hewitt, Stephen M. ^{[1
]}

Choi, Michael J. ^{[1
]}

Kopp, Jeffrey B. ^{[1
]}

Zhdanova, Olga ^{[1
]}

Hodgin, Jeffrey B. ^{[1
]}

Johnstone, Duncan B. ^{[1
]}

Adler, Sharon G. ^{[1
]}

Avila-Casado, Carmen ^{[1
]}

Neu, Alicia M. ^{[1
]}

Hingorani, Sangeeta R. ^{[1
]}

Lemley, Kevin V. ^{[1
]}

Nast, Cynthia C. ^{[1
]}

Brady, Tammy M. ^{[1
]}

Barisoni-Thomas, Laura ^{[1
]}

Fornoni, Alessia ^{[1
]}

Jennette, J. Charles ^{[1
]}

Cattran, Daniel C. ^{[1
]}

Palmer, Matthew B. ^{[1
]}

Gibson, Keisha L. ^{[1
]}

Reich, Heather N. ^{[1
]}

Mokrzycki, Michele H. ^{[1
]}

Sambandam, Kamalanathan K. ^{[1
]}

Zilleruelo, Gaston E. ^{[1
]}

Licht, Christoph ^{[1
]}

机构：

[1] Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA

来源：

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2016年 / 11卷 / 01期

基金：

美国国家卫生研究院;

关键词：

RENAL BIOPSY; NEPHROPATHY; NEPTUNE; DISEASE;

D O I：

10.2215/CJN.02560315

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Background and objectives This analysis from the Nephrotic Syndrome Study Network (NEPTUNE) assessed the phenotypic and pathology characteristics of proteinuric patients undergoing kidney biopsy and defined the frequency and factors associated with complete proteinuria remission (CRever). Design, setting, participants, & measurements We enrolled adults and children with proteinuria >= 0.5 g/d at the time of first clinically indicated renal biopsy at 21 sites in North America from April 2010 to June 2014 into a prospective cohort study. NEPTUNE central pathologists assigned participants to minimal-change disease (MCD), FSGS, membranous nephropathy, or other glomerulopathy cohorts. Outcome measures for this analysis were (1) CRever with urine protein-to-creatinine ratio (UPC) <0.3 g/g with preserved native kidney function and (2) ESRD. Continuous variables are reported as median and interquartile range (IQR; 25th, 75th percentile). Cox proportional hazards modeling was used to assess factors associated with CRever. Results We enrolled 441 patients: 116 (27%) had MCD, 142 (32%) had FSGS, 66 (15%) had membranous nephropathy, and 117(27%) had other glomerulopathy. The baseline UPC was 4.1 g/g (IQR, 1.9, 7.7) and the eGFR was 81 ml/min per 1.73 m(2) (IQR, 50, 105). Median duration of observation was 19 months (IQR, 11, 30). CRever occurred in 46% of patients, and 4.6% progressed to ESRD. Multivariate analysis demonstrated that higher prebiopsy proteinuria (hazard ratio, 0.3; 95% confidence interval, 0.2 to 0.5) and pathology diagnosis (FSGS versus MCD; hazard ratio, 0.2; 95% confidence interval, 0.1 to 0.5) were inversely associated with CRever. The effect of immunosuppressive therapy on remission varied by pathology diagnosis. Conclusions In NEPTUNE, the high frequency of other pathology in proteinuric patients affirms the value of the diagnostic kidney biopsy. Clinical factors, including level of proteinuria before biopsy, pathology diagnosis, and immunosuppression, are associated with complete remission.

引用

页码：81 / 89

页数：9

共 50 条

[11] Complete remission of nephrotic syndrome in an infant with focal segmental glomerulosclerosis: is it renin–angiotensin blockade?
Neveen A. Soliman
Magdi Francis
Saskia F. Heeringa
Gil Chernin
Pediatric Nephrology, 2009, 24 : 1065 - 1070
[12] Complete remission of nephrotic syndrome in a woman with renal amyloidosis due to familial mediterranean fever
Heras, Manuel
Saiz, Ana
Jose Fernandez-Reyes, Maria
Molina, Alvaro
Astrid Rodriguez, Maria
Callejasa, Ramiro
NEFROLOGIA, 2016, 36 (03): : 331 - 332
[13] Anakinra induces complete remission of nephrotic syndrome in a patient with familial mediterranean fever and amyloidosis
Sevillano, Angel M.
Hernandez, Eduardo
Gonzalez, Esther
Mateo, Isabel
Gutierrez, Eduardo
Morales, Enrique
Praga, Manuel
NEFROLOGIA, 2016, 36 (01): : 63 - 66
[14] Bisalbuminemia during Remission of Nephrotic Syndrome
Akhmouch, I.
Alayoud, A.
Bahadi, A.
Zajjari, Y.
Montasser, D.
El Allam, M.
Oualim, Z.
SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2012, 23 (06) : 1251 - 1253
[15] REMISSION OF NEPHROTIC SYNDROME ON LOVASTATIN TREATMENT
GONZALO, A
PASCUAL, J
MAMPASO, F
ORTUNO, J
NEPHRON, 1994, 66 (02): : 233 - 234
[16] REMISSION OF NEPHROTIC SYNDROME IN RENAL AMYLOIDOSIS
LOWENSTEIN, J
GALLO, G
NEW ENGLAND JOURNAL OF MEDICINE, 1970, 282 (03): : 128 - +
[17] SPONTANEOUS REMISSION OF NEPHROTIC SYNDROME IN AMYLOIDOSIS
MERY, JP
BRITISH MEDICAL JOURNAL, 1978, 2 (6131): : 202 - 203
[18] Initiation of renin–angiotensin system inhibitors and first complete remission in patients with primary nephrotic syndrome: a nationwide cohort study
Sayaka Shimizu
Kakuya Niihata
Hiroki Nishiwaki
Yugo Shibagaki
Ryohei Yamamoto
Kosaku Nitta
Tatsuo Tsukamoto
Shunya Uchida
Asami Takeda
Hirokazu Okada
Ichiei Narita
Yoshitaka Isaka
Noriaki Kurita
Clinical and Experimental Nephrology, 2023, 27 : 480 - 489
[19] Complete remission induced by tacrolimus and low-dose prednisolone in adult minimal change nephrotic syndrome: A pilot study
Kim, Yong Chul
Lee, Tae Woo
Lee, Hajeong
Koo, Ho Suk
Oh, Kook-Hwan
Joo, Kwon Wook
Kim, Suhnggwon
Chin, Ho Jun
KIDNEY RESEARCH AND CLINICAL PRACTICE, 2012, 31 (02) : 112 - 117
[20] Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome
Nozu, K
Iijima, K
Fujisawa, M
Nakagawa, A
Yoshikawa, N
Matsuo, M
PEDIATRIC NEPHROLOGY, 2005, 20 (11) : 1660 - 1663

← 1 2 3 4 5 →